Skip to content

Public FDA record

Z-2258-2024: Prucka 3 Amplifier Model #P1801PA used with CardioLab AltiX electrophysiology recording system and ComboL

Recall record Z-2258-2024 for GE Medical Systems Information Technologies Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2258-2024
Company in FDA record
GE Medical Systems Information Technologies Inc
FDA classification date
Jul 3, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Capacitors in certain Prucka 3 Amplifiers used with CardioLab / ComboLab systems could fail resulting in transient oscillations on the display and inability to view surface and intracardiac ECG waveforms.

Source facts

Action
The recalling firm issued letters on and dated 4/22/2024 via traceable means informing the consignee of the affected product details, safety issue, and actions to be taken by the customer/user. The consignee was informed they can continue to use the Prucka 3 Amplifiers with the CardioLab/ComboLab systems with the following conditions: (1) Ensure additional devices are immediately available to monitor surface and intracardiac ECG waveforms in order to complete the study (e.g. patient monitor, 3D mapping system, etc.) until the device is corrected; (2) In the event the Prucka 3 Amplifier malfunction occurs during the case with the loss of ECG waveforms, use an alternate device; (3) Ensure the hospital staff are familiar with utilizing the Direct Stimulator Connections on the CIM Block(s). This allows pacing from the stimulator if the amplifier is not functioning properly. The consignee is to ensure all potential users in the facility are made aware of this safety notification and the recommended actions. An acknowledgment form was enclosed for completion and return no later than 30 days from receipt of the letter. GE HealthCare will correct all affected devices and a representative will contact the consignee to arrange for the correction.
Initiated
2024-04-22
Root cause
Process control
Distribution
Worldwide - US Nationwide distribution in the states of AK, AZ, CA, CO, FL, GA, IL, KY, MA, ME, MN, MO, NC, NJ, NY, OH, OR, PA, TN, TX, and WA. The countries of Belgium, Canada, Czech Republic, France, Germany, Ireland, Israel, Italy, Japan, Republic of Korea, and Singapore.
Recall number
Z-2258-2024
Recall status
Open, Classified
CDRH record ID
208103
FDA classified
2024-07-03
Recall event number
94717

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗